Comparative Efficacy and Safety of Peficitinib 25, 50, 100, and 150 mg in Patients with Active Rheumatoid Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Published in: Clinical drug investigation (2020)

Peficitinib 50, 100, and 150 mg once daily was effective in treating active RA, without causing a significant risk for AEs.

Keyphrases